Cargando…
Study Designs for Evaluation of Combination Treatment: Focus on Individual Patient Benefit
Combination treatment, i.e., the use of two or more drugs for the same condition, is frequent in medicine if monotherapy yields an insufficient therapeutic response. We review and challenge clinical study designs and formats of reporting outcomes for the evaluation of the benefit/risk ratio of combi...
Autores principales: | Michel, Martin C., Staskin, David |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8869609/ https://www.ncbi.nlm.nih.gov/pubmed/35203479 http://dx.doi.org/10.3390/biomedicines10020270 |
Ejemplares similares
-
An Evaluation of the Efficacy and Safety of Vibegron in the Treatment of Overactive Bladder
por: Frankel, Jeffrey, et al.
Publicado: (2022) -
Clinician Conceptualization of the Benefits of Treatments for Individual Patients
por: Morgan, Daniel J., et al.
Publicado: (2021) -
Differential benefit risk assessment of DOACs in the treatment of venous thromboembolism: focus on dabigatran
por: Leung, Timothy S, et al.
Publicado: (2015) -
Comment on: update on the management of overactive bladder
por: Staskin, David
Publicado: (2022) -
Absorbable stent: focus on clinical applications and benefits
por: Gonzalo, Nieves, et al.
Publicado: (2012)